CureVac (CVAC) Other Non-Current Liabilities (2019 - 2025)
Historic Other Non-Current Liabilities for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $209.5 million.
- CureVac's Other Non-Current Liabilities rose 42766.94% to $209.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $209.5 million, marking a year-over-year increase of 42766.94%. This contributed to the annual value of $31.6 million for FY2024, which is 4214.3% down from last year.
- According to the latest figures from Q3 2025, CureVac's Other Non-Current Liabilities is $209.5 million, which was up 42766.94% from $41.1 million recorded in Q2 2025.
- CureVac's 5-year Other Non-Current Liabilities high stood at $209.5 million for Q3 2025, and its period low was $302008.4 during Q4 2021.
- For the 5-year period, CureVac's Other Non-Current Liabilities averaged around $65.7 million, with its median value being $43.7 million (2025).
- In the last 5 years, CureVac's Other Non-Current Liabilities surged by 2061517.55% in 2022 and then plummeted by 6804.25% in 2023.
- Over the past 5 years, CureVac's Other Non-Current Liabilities (Quarter) stood at $302008.4 in 2021, then soared by 20615.18% to $62.6 million in 2022, then dropped by 12.78% to $54.6 million in 2023, then tumbled by 42.14% to $31.6 million in 2024, then surged by 563.7% to $209.5 million in 2025.
- Its Other Non-Current Liabilities was $209.5 million in Q3 2025, compared to $41.1 million in Q2 2025 and $27.8 million in Q1 2025.